PEPperCHIP® Coronavirus SARS-CoV-2 Proteome Microarray|Tokyo Future Style is a bio-tech trading company

PEPperPRINT has developed a peptide microarray against the genome of the SARS-CoV-2 virus (Severe Acute Respiratory Syndrome Coronavirus 2, previously 2019-nCoV) in response to the COVID-19 pandemic that was discovered late 2019.

The microarray is effective for purposes such as:

➤ identify, profile, and compare specific IgG and IgM antibody responses in patient or animal sera

➤ screen viral antigens to find and characterize immunodominant epitopes

Example Usage – Antibody Fingerprinting

The entire Coronavirus SARS-CoV-2 viral proteome is translated into overlapping peptides and printed onto glass slides. Patient sera is incubated on the chip and antibodies present in the sample bind to epitopes recognized within individual peptides. The resulting response profile may be compared across different samples to monitor B-cell responses over time, or to determine immunodominant epitopes that may be further validated as potential disease-specific biomarkers.

Poster

Epitope signatures in COVID-19 patients with mild and severe disease outcome

Product Information

SPC.051.001	PEPperCHIP® SARS-CoV-2 Proteome Microarray
Target	SARS-CoV-2	Test / Microarray	One array with 5,347 peptides printed in duplicate
Contents	Full proteome of SARS-CoV-2 (GenBank ID: MN908947.3) plus 49 mutations of the B1.1.7, 501.V2, B1.1.28 and P.1 Masnau variants and all spike protein mutations of the Alpha, Beta, Gamma, Delta, Delta Plus and Omicron variants of concern
Details	Data sheet (pdf) / Layout (xlsx)
Compatible With	3/1 well PEPperCHIP® Incubation Tray

Back to Introduction Page of PEPperPRINT